LiveWell Study Reaches Major Milestone, What it Means for Earlier Liver Risk Detection

A large-scale UK study focused on liver health has reached a significant milestone, completing recruitment of nearly 1,000 participants in under a year. The LiveWell study, delivered in partnership with Somerset NHS Foundation Trust, Predictive Health Intelligence, and Sano Genetics, demonstrates how data-led approaches can improve both the speed and quality of clinical research.

For MyLife365.me, the public-facing arm of Tawazun Health, this milestone highlights a clear shift in how people can be identified earlier for potential health risks and supported before conditions progress.

A new way to identify liver health risks earlier

One of the biggest challenges in liver disease is timing. Many people show minor irregularities in blood tests, but it is not always clear who needs further investigation. This often leads to delays in diagnosis, when intervention becomes more difficult.

The LiveWell study addressed this by using existing NHS data to identify individuals who may be at higher risk. By analysing historic blood test results alongside genetic information, researchers were able to target the right participants more accurately.

This approach moves away from broad screening and instead focuses on precision, helping to identify people earlier, when lifestyle changes and monitoring can still make a meaningful difference.

Strong engagement shows people want proactive health insight

The study achieved:

• 1,300 visitors to the study landing page
• 95% engagement rate
• 76% conversion to sign-up
• 996 participants enrolled, with over 99% ordering a genetic test

These results suggest a strong appetite for more personalised, proactive health insights. People are willing to engage when the process is simple, relevant, and clearly beneficial.

Through digital tools, participants were able to complete consent, arrange testing, and manage their involvement without unnecessary complexity. This reflects a broader shift towards more accessible and user-led healthcare experiences.

What this means for patients and everyday health

For participants, the study has already had a meaningful impact. Early identification of liver and metabolic risks allows for timely intervention, which can improve long-term outcomes.

This is where MyLife365.me plays an important role. As the public-facing arm of Tawazun Health, it supports individuals in understanding their health data, tracking key lifestyle factors, and building habits that reduce risk over time.

Rather than waiting for symptoms to appear, the focus shifts towards:

• Monitoring patterns in health data
• Understanding personal risk factors
• Making informed lifestyle adjustments

This kind of proactive approach helps people stay in control of their health in a practical and sustainable way.

Supporting the NHS without adding pressure

Another important outcome from the LiveWell study is how it supports the NHS. By using existing data and digital workflows, research can be delivered at scale without placing additional strain on clinical teams.

This matters as the UK continues to expand its role in global clinical research. Efficient recruitment and engagement make studies more viable, helping to bring new insights and treatments into practice faster.

The LiveWell model shows that with the right use of data and technology, research can be both effective and efficient.

A scalable model for future health research

Recruitment delays are one of the most common reasons clinical trials fail. Many studies struggle to reach their targets on time, which slows progress and increases costs.

LiveWell offers a different model. By combining data analysis, digital engagement, and strong partnerships, it demonstrates that large-scale recruitment can be achieved quickly and effectively.

This has wider implications beyond liver health. The same approach could be applied to other conditions, helping researchers identify the right participants earlier and improve outcomes across multiple areas of healthcare.

How this connects to MyLife365.me

The outcomes of the LiveWell study reflect a wider movement towards personalised, preventative health. MyLife365.me, as the public-facing arm of Tawazun Health, brings these principles into everyday life.

It focuses on helping individuals:

• Build awareness of their health patterns
• Track key lifestyle habits such as sleep, nutrition, and activity
• Take practical steps to reduce long-term risk

By connecting clinical insight with daily habits, MyLife365.me bridges the gap between research and real-world health decisions.

Looking ahead

Participant follow-up for the LiveWell study is ongoing, with further results expected later this year. As more data becomes available, it will provide deeper insight into how early identification and targeted intervention can improve outcomes.

For individuals, the direction is clear. Health is becoming more personalised, more data-driven, and more proactive.

For MyLife365.me, this milestone reinforces its role in making these advances accessible, helping people take meaningful steps towards better long-term health.